Kedudukan dalam Saham
#41406
MabCure Inc., a development stage company, engages in developing and... MabCure Inc., a development stage company, engages in developing and commercializing its proprietary antibody technology for the early detection of cancer, and for the creation of specific therapeutics against cancer. It owns a proprietary technology for the generation of monoclonal antibodies against desired antigens, such as cancer markers. The company was formerly known as Smartec Holdings, Inc. and changed its name to MabCure Inc. in January 2008 to reflect its new business plan. MabCure Inc. was founded in 2006 and is based in White Plains, New York.
Harga Saham
$0.0003
Disegerakkan terakhir: 2026-08-11
Perubahan (1 tahun)
200.00%
Perdagangan MabCure Inc. (MBCI)
Harga MBCI dengan permodalan pasaran b
Modal pasaran bagi MabCure Inc.(MBCI)
Modal Pasaran: $21.97K
Sehingga August 2026, MabCure Inc. mempunyai modal pasaran sebanyak $21.97K. Ini menjadikan MabCure Inc. syarikat ke-41406th paling bernilai di dunia mengikut data kami. Kapitalisasi pasaran ialah nilai keseluruhan saham syarikat tersenarai yang berada dalam edaran dan lazimnya digunakan untuk menilai nilai syarikat tersebut.
Sejarah modal pasaran MabCure Inc. dari 2007 hingga 2026
MBCI berbanding dengan 5 teratas yang paling popular stocks
| Harga MBCI |
|
Aset B |
Pasaran B |
Hasilnya |
|
|
|
|
$5.383T
|
+24,508,807,134.32%
|
|
|
|
|
$4.423T
|
+20,138,362,039.83%
|
|
|
|
|
$4.160T
|
+18,940,903,323.46%
|
|
|
|
|
$3.663T
|
+16,677,991,570.18%
|
|
|
|
|
$2.891T
|
+13,162,890,051.27%
|
